A. Graziano

发表

Synthesis and complete 1H, 13C and 15N NMR assignment of substituted isoxazolo[3,4‐d]pyridazin‐7(6H)‐ones

N. Haider, W. Holzer, V. Dal Piaz, 2005, Magnetic resonance in chemistry : MRC.

Synthesis and Evaluation as Antitubercular Agents of 5‐Arylethenyl and 5‐(Hetero)aryl‐3‐Isoxazolecarboxylate

S. Franzblau, B. Wan, C. Vergelli, 2013 .

Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.

M. Loza, M. Cadavid, J. Díaz, 2010, Bioorganic & medicinal chemistry.

Synthesis, HPLC enantioresolution, and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists.

G. Bartolucci, C. Vergelli, M. Giovannoni, 2013, Chirality.

Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists.

G. Bartolucci, C. Vergelli, M. Giovannoni, 2012, Bioorganic & medicinal chemistry.

6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

J. Holderness, R. Ye, C. Vergelli, 2009, Journal of medicinal chemistry.

Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.

C. Vergelli, M. Giovannoni, A. Cilibrizzi, 2009, Journal of medicinal chemistry.

Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors

V. D. Piaz, C. Vergelli, M. Giovannoni, 2007, Journal of enzyme inhibition and medicinal chemistry.

New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.

C. Vergelli, M. Giovannoni, V. Dal Piaz, 2005, Bioorganic & medicinal chemistry letters.

Synthesis and Pharmacological Evaluation of New Pyridazin‐Based Thioderivatives as Formyl Peptide Receptor (FPR) Agonists

A. Khlebnikov, C. Vergelli, M. Giovannoni, 2013 .

Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action.

C. Ghelardini, N. Galeotti, C. Vergelli, 2006, Journal of medicinal chemistry.

Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists.

A. Khlebnikov, C. Vergelli, M. Giovannoni, 2013, European journal of medicinal chemistry.

4-Amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: Synthesis, SARs, and preliminary studies on the mechanism of action.

C. Vergelli, M. Giovannoni, V. Dal Piaz, 2007, Bioorganic & medicinal chemistry.

PDE5 inhibitors and their applications.

C. Vergelli, M. Giovannoni, V. Dal Piaz, 2010, Current medicinal chemistry.

Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activity.

P. Puccini, C. Vergelli, M. Giovannoni, 2010, Bioorganic & medicinal chemistry.

Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.

A. Khlebnikov, C. Vergelli, M. Giovannoni, 2013, Journal of medicinal chemistry.

Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.

A. Khlebnikov, V. D. Piaz, C. Vergelli, 2011, Bioorganic & medicinal chemistry.

Chemical Composition of the Essential Oil of Pistacia lentiscus L.

M. Michelozzi, A. Graziano, V. Vidrich, 2004 .

Synthesis and evaluation as PDE4 inhibitors of pyrimidine‐2,4‐dione derivatives

R. Matucci, C. Vergelli, M. Giovannoni, 2011 .

New Pyrazolo[1′,5′:1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as Potent and Selective PDE5 Inhibitors.

V. D. Piaz, C. Vergelli, M. Giovannoni, 2005 .

4-amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action.

C. Ghelardini, C. Vergelli, M. Giovannoni, 2007, Journal of medicinal chemistry.

Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction.

C. Vergelli, M. Giovannoni, A. Graziano, 2006, Journal of medicinal chemistry.